Ovid Therapeutics (OVID) Tax Provisions (2021 - 2022)
Ovid Therapeutics (OVID) reported Tax Provisions of $50000.0 for Q1 2022, down 90.01% on a YoY basis from $500277.0 in Q1 2021, and up 114.3% quarter-over-quarter from -$349714.0 in Q4 2021.
Ovid Therapeutics (OVID) Tax Provisions (2021 - 2022) Analysis & Trends
Ovid Therapeutics has reported Tax Provisions for 2 years, with the latest figure at $50000.0 in Q1 2022.
- For the quarter ending Q1 2022, Tax Provisions fell 90.01% year-over-year to $50000.0; the trailing twelve-month figure through Dec 2022 stood at $50000.0 (down 96.24% YoY), and the FY2021 full-year result was $1.3 million, changed N/A from the prior year.
- Tax Provisions for Q1 2022 stood at $50000.0, up from -$349714.0 in the prior quarter.
- The five-year high for Tax Provisions was $1.5 million in Q2 2021, with the low at -$349714.0 in Q4 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -11.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | 216,000.00 |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -859,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 221.50 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Ovid Therapeutics | 311.83 Mn | 156.31 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 50,000.00 |
| Dec 31, 2021 | -349,714.00 |
| Sep 30, 2021 | -294,829.00 |
| Jun 30, 2021 | 1.47 Mn |
| Mar 31, 2021 | 500,277.00 |